US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.73

+1.431.47%

Post-market: 98.69-0.0465-0.05%19:30 EDT

Volume:7K

Turnover:644.33K

Market Cap:406.77M

PE:55.06

High:98.82

Open:97.68

Low:97.68

Close:97.30

52wk High:98.82

52wk Low:67.56

Shares:4.12M

Float Shares:4.12M

Volume Ratio:0.28

T/O Rate:0.16%

Dividend:1.55

Dividend Rate:1.57%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.64

PE(LYR):5.29

Loading ...

Overview Company News Filings

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Political and General News Events from August 25

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

Political and General News Events from August 24

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live

Alnylam to present new clinical data on ATTR, hypertension at ESC Congress

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-08-21

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PBE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":98.7315,"timestamp":1787688000000,"preClose":97.301,"halted":0,"volume":6544,"hourTrading":{"tag":"盘后","latestPrice":98.685,"preClose":98.7315,"latestTime":"19:30 EDT","volume":11,"amount":1086.1635,"timestamp":1787700601847,"change":-0.0465,"changeRate":-0.000471,"amplitude":0},"delay":0,"changeRate":0.014701801625882518,"floatShares":4120000,"shares":4120000,"eps":1.793292,"marketStatus":"Not Yet Opened","change":1.4305,"latestTime":"08-25 16:00:00 EDT","open":97.68,"high":98.82,"low":97.68,"amount":644330.0273600001,"amplitude":0.011716,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":97.301,"sharesOutstanding":3180000,"nav":97.25464,"aum":401661663.2,"dividendRate":0.01567,"bidAskSpread":0.002967,"postHourTrading":{"tag":"盘后","latestPrice":98.685,"preClose":98.7315,"latestTime":"19:30 EDT","volume":11,"amount":1086.1635,"timestamp":1787700601847,"change":-0.0465,"changeRate":-0.000471,"amplitude":0},"volumeRatio":0.281845,"impliedVol":0.1495,"impliedVolPercentile":0.0757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4120000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.281845,"shares":4120000,"dividePrice":1.5471,"high":98.82,"amplitude":0.011716,"preClose":97.301,"low":97.68,"week52Low":67.56,"pbRate":"1.64","psRate":"236.96","week52High":98.82,"institutionHeld":0.2552,"latestPrice":98.7315,"eps":1.793292,"divideRate":0.01567,"volume":6544,"delay":0,"ttmEps":1.793292,"open":97.68,"prevYearClose":82.15,"prevWeekClose":97.59,"prevMonthClose":89.6108,"prevQuarterClose":89.6486,"fiveDayClose":95.28,"twentyDayClose":91.7375,"sixtyDayClose":83.8038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662215752","title":"Biogen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662215752","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662215752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:59","pubTimestamp":1787691540,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  advanced 1.21% to $220.77 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Biogen Inc. closed 0.62% short of its 52-week high of $222.15, which the company reached on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $273.14, Pfizer Inc.  rose 2.15% to $28.57, and AbbVie Inc.  rose 0.48% to $265.79.Trading volume  remained 712,698 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4585","LU0320765992.SGD","BK4588","PBE","IE00B19Z9P08.USD","BIIB","BK4139","IE00B894F039.SGD","LU0234570918.USD","BK4533","LU0889565916.HKD","BMED","IE00B19Z9Z06.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370257","title":"Political and General News Events from August 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662370257?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:25","pubTimestamp":1787664343,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 25Aug 25 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1983299246.USD","LU2468319806.SGD","PJP","LU0868494617.USD","LU2242652126.USD","LU0320765992.SGD","LU0122379950.USD","IE00BJT1NW94.SGD","BIB","BK4588","IE0009355771.USD","IE00B2B36J28.USD","LU0289739699.SGD","LU0889565916.HKD","LU1061106388.HKD","TBXU","BK4581","BK4599","SG9999001440.SGD","BK4139","LU0058720904.USD","BK4533","LU1057294990.SGD","IE0002141913.USD","BK4534","IBBQ","LU2242646821.SGD","BK4585","LU2089984988.USD","IE00B4R5TH58.HKD","BBH","LU1571399168.USD","LU1023059063.AUD","PBE","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","AMGN","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662423737","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662423737","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662423737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:15","pubTimestamp":1787663703,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  slightly advancing and the iShares Biotechnology ETF  up 0.2%.Immatics  shares were up more than 13% after the company said it has agreed to sell about 12.9 million ordinary shares at $8.69 each, and in lieu of ordinary shares to certain investors, pre-funded warrants to buy up to approximately 4.3 million ordinary shares at $8.689 per pre-funded warrant.Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to statements from Veeva. Shares of Veeva Systems were down 0.1% premarket.Bausch + Lomb  stock was up more than 1% after the company said it plans to advance two of its pharmaceutical pipeline assets to new trials based on latest clinical results.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","LU0234570918.USD","LABU","LU0109394709.USD","BK4588","LU0823434740.USD","BK4532","LU2362540622.SGD","BK4581","LU0882574055.USD","LU2089984988.USD","BK4139","HCSG","IBBQ","XLV","IMTX","LU2023250504.SGD","BK4613","LU0128526141.USD","LU2468319806.SGD","IE00B19Z9P08.USD","LU0320765992.SGD","REGN","BMED","EKG","LU1917777945.USD","LU0053666078.USD","VEEV","BK4533","LU2237438978.USD","BLCO","BBH","BK4528","LU0114720955.EUR","LGHT","BK4198","BK4534","LU1974910355.USD","XBI","IE00B894F039.SGD","LU0289739699.SGD","LU0058720904.USD","PBE","TBXU","IBB","LU0029874061.USD","LU0170899867.USD","LU0889565916.HKD","BIIB","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731506","title":"Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731506","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:41","pubTimestamp":1787658092,"startTime":"0","endTime":"0","summary":"Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to Tuesday statements from Veeva.No financial details were disclosed.Biogen will use Veeva Vault CRM as its agentic commercial foundation to deliver drugs to patients, while Regeneron plans to use the platform to generate commercial evidence that will back treatment adoption, Veeva said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","BK4532","LU2362541513.USD","LU0109394709.USD","LU0823434583.USD","BIIB","LU1917777945.USD","LU0320765992.SGD","BK4534","LU2362541273.HKD","IBB","LGHT","LU0053666078.USD","LU0823434740.USD","LU0289739699.SGD","TBXU","IE00B894F039.SGD","LU0266013472.USD","LU0114720955.EUR","LU0889565916.HKD","LU2106854487.HKD","BK4533","LU0170899867.USD","IE00B19Z9Z06.USD","LU2023250504.SGD","LU2468319806.SGD","BK4613","PBE","IE00B19Z9P08.USD","LU1989764664.SGD","LU2237438978.USD","BMED","BK4528","EKG","LU2362540622.SGD","BK4588","IBBQ","BBH","LU0058720904.USD","LU1974910355.USD","BK4585","BK4139","LU0234570918.USD","LU1989764748.USD","REGN","LU0823416689.USD","VEEV","BK4167","BK4504","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273574","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273574?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:40","pubTimestamp":1787654408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GE Healthcare Technologies Inc (GEHC), Biogen (BIIB)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0354030511.USD","PPA","LU1551013425.SGD","XLV","LU2756315664.SGD","ONC","DFEN","BK4139","MISL","MDCO","LU2543165471.USD","XAR","LGHT","GEHC","LU2264538146.SGD","XBI","LU1551013342.USD","BK4588","LU0354030438.USD","LU0109394709.USD","LU0889565916.HKD","PBE","ITA","BK4526","LU1988902786.USD","BK4581","LABU","LU2168564065.EUR","GE","BK4187","LU0077335932.USD","BK4543","BMED","NATO","IE00B894F039.SGD","LU0689472784.USD","LU1280957306.USD","LU0868494617.USD","BK4082","TRUI","BIIB","IE00B19Z9P08.USD","LU1366192091.USD","UXI","EXI","LU2168564222.USD","LU1066051498.USD","LU0689626769.HKD","LU0353189763.USD","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662786682","title":"Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662786682","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662786682?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:37","pubTimestamp":1787632638,"startTime":"0","endTime":"0","summary":"Viavi Solutions (VIAV) has launched Vertex 6.0, a new version of its channel emulation platform designed for 6G and Wi-Fi 7/8 testing. Investors are assessing what this expanded wireless testing capability might imply for the stock.\nSee our latest analysis for Viavi Solutions.\nThe Vertex 6.0 launch arrives after a sharp pullback in Viavi Solutions' share price, with the stock down 20.13% over the past week and 31.31% over 90 days. However, year to date the share price return is 103.58% and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1093756325.SGD","LU2089984988.USD","SG9999013999.USD","IE0009355771.USD","BK4020","IE00B19Z3581.USD","LU2065169927.USD","IE00B4R5TH58.HKD","BK4023","LU1559883803.SGD","LU2065171311.SGD","LU2362541273.HKD","IBB","VIAG","LU2236285917.USD","LU0289739699.SGD","TBXU","IE00B894F039.SGD","LU1093756168.USD","IDNA","BIB","LU2468319806.SGD","LU0240877869.USD","PBE","IE00B19Z9P08.USD","IE0002141913.USD","BK4567","IE00BZ9MQY76.HKD","LU2237438978.USD","VERX","LU2362540622.SGD","IBBQ","BBH","IE00BFTCPJ56.SGD","LU1585245621.USD","GNMX","LU2417539215.USD","LU0079474960.USD","LU1069344957.HKD","LU1778281490.HKD","LU2462157665.USD","IE00BJJMRZ35.SGD","VIAV","BK4139","LU0234570918.USD","LU0757428866.USD","IE0002270589.USD","LU2065170008.USD","LU0205194284.USD","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206197","title":"Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206197?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.03% to $443.84 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.26% to 53,417.16 and the S&P 500 Index  falling 0.28% to 7,652.86.This was the stock's second consecutive day of gains.Amgen Inc. hit a new 52-week high, surpassing its previous peak of $443.20, which the company reached on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 1.04% to $273.04, Pfizer Inc.  fell 0.36% to $27.97, and AbbVie Inc.  fell 0.17% to $264.52.Trading volume  remained 382,792 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","TBXU","LU2242646821.SGD","LU1057294990.SGD","IBB","PBE","BK4581","SG9999001440.SGD","LU2112291526.USD","BK4566","BK4599","IE0002141913.USD","LU0109394709.USD","IE00B2B36J28.USD","LU1061106388.HKD","BK4534","IE00BFTCPJ56.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","AMGN","LU0058720904.USD","IE00B4R5TH58.HKD","IBBQ","BK4585","BK4588","BK4533","BBH","LU0889565916.HKD","04332","IE0009355771.USD","LU0289739699.SGD","LU1983299246.USD","PJP","LU1571399168.USD","LU2242652126.USD","BK4139","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729270","title":"Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662729270?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:31","pubTimestamp":1787589063,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. is moving ahead with MARITIME-2-EXTENSION, a Phase 3 trial that t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","BK4566","IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","LU1983299246.USD","BBH","LU2242652126.USD","IBBQ","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","BK4533","LU2242646821.SGD","AMGN","SG9999001440.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","IBB","LU0868494617.USD","BK4585","LU1057294990.SGD","LU2112291526.USD","PBE","BK4139","LU2089984988.USD","LU0289739699.SGD","IE00B2B36J28.USD","PSIL","BIB","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","PJP","LU0058720904.USD","LU2468319806.SGD","BK4588","LU0109394709.USD","BK4534","BK4599","LU1023059063.AUD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","HELX","GNMX","GNOM","IDNA","IBB","PBE","MEDX","HTEC","XT","FDIF","BMED","LFSC","BK4585","SYNB","WDNA","JDOC","TMAT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271512","title":"Political and General News Events from August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271512?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:19","pubTimestamp":1787577552,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 24Aug 24 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L0XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4534","AMGN","PBE","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","LU2112291526.USD","PJP","TBXU","BK4585","LU2242652126.USD","LU0889565916.HKD","BBH","IBBQ","LU1057294990.SGD","BIB","BK4566","BK4599","LU2242646821.SGD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","BK4533","IE00B2B36J28.USD","LU0868494617.USD","LU1571399168.USD","LU0122379950.USD","BK4588","LU2468319806.SGD","LU2089984988.USD","IBB","IE00BJT1NW94.SGD","LU0109394709.USD","LU0289739699.SGD","LU1023059063.AUD","LU0058720904.USD","SG9999001440.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661127910","title":"Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661127910","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661127910?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:55","pubTimestamp":1787576112,"startTime":"0","endTime":"0","summary":"Biogen  and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease.The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease.The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver.LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IE00B19Z9Z06.USD","BK4588","IE00B19Z9P08.USD","BIIB","LU0234570918.USD","BK4533","BMED","LU0320765992.SGD","PBE","BK4585","IE00B894F039.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279552","title":"Alnylam to present new clinical data on ATTR, hypertension at ESC Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279552","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279552?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575225,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis, ATTR,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","PBE","BK4548","BK4139","BK4588","LU0114720955.EUR","LU0882574055.USD","LU0320765992.SGD","BK4585","ATTR","LU0109394709.USD","ALNY","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279670","title":"Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279670","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279670?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575209,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that once weekly lecanemab-irmb subcutaneous injection is now available in the U.S. for initiation therap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-once-weekly-lecanemab-irmb-availability-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-once-weekly-lecanemab-irmb-availability-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B894F039.SGD","BK4532","BK4588","BMED","LU0889565916.HKD","ESAIY","LU0109394709.USD","BK4139","IE00B19Z9Z06.USD","LU0234570918.USD","BK4007","LU0320765992.SGD","BIIB","IE00B19Z9P08.USD","BK4533","PBE","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661313276","title":"Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661313276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661313276?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:02","pubTimestamp":1787572944,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU0889565916.HKD","BK4585","LU0109394709.USD","BMED","LU0234570918.USD","PBE","IE00B19Z9Z06.USD","BK4533","IE00B19Z9P08.USD","BK4588","LU0320765992.SGD","IE00B894F039.SGD","BIIB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU0122379950.USD","BK4139","PBE","IBB","LU0889565916.HKD","LU0289739699.SGD","LU0109394709.USD","BK4566","IE0009355771.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU2112291526.USD","TBXU","LU0058720904.USD","IE0002141913.USD","BIB","LU0868494617.USD","IBBQ","AMGN","IE00B2B36J28.USD","BBH","LU1571399168.USD","BK4581","LU0320765992.SGD","BK4534","PJP","LU2468319806.SGD","BK4585","LU1023059063.AUD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4588","BK4533","LU2242652126.USD","LU1057294990.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2236285917.USD","BK4023","ARTY","LU1674673428.USD","LU2417539215.USD","BK4567","LU0240877869.USD","SG9999001176.SGD","LU1559883803.SGD","IE0002141913.USD","LU2065171311.SGD","IE00B4R5TH58.HKD","LU1585245621.USD","IBBQ","LU2065170008.USD","BK4585","VERX","LU2462157665.USD","LU0061475181.USD","BK4588","CHAT","LU0205194284.USD","LU1069344957.HKD","LU2362540622.SGD","LU0889565916.HKD","VTHR","IDNA","VRTX","AGIX","LU0432979614.USD","PBE","VIAV","LU2089984988.USD","BK4532","LU0417517546.SGD","TBXU","BBH","AIPO","IE00B19Z9Z06.USD","SG9999013999.USD","VIAG","IBB","LU1093756325.SGD","LU0234570918.USD","QTOC","GNMX","LU2065171402.SGD","IE00B2B36J28.USD","BIB","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1839511570.USD","IE00BZ9MQY76.HKD","LU0965509101.SGD","LU0882574055.USD","LU1934455863.HKD","BK4007","IE00BN0W2V16.EUR","LU0320765992.SGD","SG9999015986.USD","LU2456880835.USD","04332","LU1023059063.AUD","LU0061475181.USD","LU0861579265.USD","LU1061106388.HKD","IE00B19Z9P08.USD","BK4139","LU2112291526.USD","AMGN","LU1917777945.USD","BK4532","LU1066053197.SGD","LU2087621335.USD","LU0432979614.USD","LU1778281490.HKD","LU1035775433.USD","BK4583","TBXU","LU0965509010.AUD","LU1585245621.USD","SG9999013999.USD","IE00B3T34201.USD","LU2324357040.USD","VRTX","LU2362540622.SGD","SG9999015952.SGD","LU0823434583.USD","LU0058720904.USD","LU2089984988.USD","LU0868494617.USD","LU1983299246.USD","PBE","SG9999001176.USD","LU0109394709.USD","IE00BSNM7G36.USD","LU0965509283.SGD","LU1093756325.SGD","BK4567","LU1093756168.USD","GNMX","LU1674673691.USD","LU2106854487.HKD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0256863811.USD","REGN","LU1037948897.HKD","LU2023250504.SGD","IE00B2B36J28.USD","LU0965508806.USD","BK4578","LU0053666078.USD","IBB","LU0859254822.USD","LU1430594728.SGD","MEDI","LU0289739699.SGD","IE00BN0W2W23.USD","LU0234570918.USD","LU1571399168.USD","LU2236285917.USD","BMED","BK4550","LU0823434740.USD","BIB","IE00B7SZLL34.SGD","BK4599","IBBQ","LU0417517546.SGD","LU0114720955.EUR","LU1066051498.USD","IE00B19Z3581.USD","IE0002270589.USD","IDNA","IE00BN0W2T93.GBP","BK4566","LU1037948541.HKD","LU2462157665.USD","LU0154245673.USD","LU2237438978.USD","LU1934455277.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD","SG9999015978.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1974910355.USD","BK4581","LU1934455194.USD","LU2242652126.USD","LU2242646821.SGD","XBI","LU0823416689.USD","LU2362541273.HKD","IE0002141913.USD","BK4534","BK4533","LU1674673428.USD","IE00BJJMRZ35.SGD","GILD","BK4588","BK4568","SGXZ57979304.SGD","LU0122379950.USD","LU2417539215.USD","PJP","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0079474960.USD","IE0009355771.USD","LU0154245756.USD","LU2362541513.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","TMED","BK4585","SG9999015945.SGD","JAZZ","SG9999001176.SGD","BBH","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661375290","title":"Biogen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2661375290","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661375290?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:57","pubTimestamp":1787345820,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  advanced 1.13% to $216.78 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.43% to 7,674.37 and the Dow Jones Industrial Average  rising 0.98% to 53,277.01.Biogen Inc. closed 2.42% below its 52-week high of $222.15, which the company achieved on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.07% to $270.24, Pfizer Inc.  rose 1.01% to $28.07, and AbbVie Inc.  rose 1.20% to $264.96.Trading volume  remained 497,941 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0889565916.HKD","BK4139","BMED","IE00B19Z9P08.USD","BIIB","IE00B894F039.SGD","LU0234570918.USD","LU0320765992.SGD","PBE","LU0109394709.USD","BK4585","IE00B19Z9Z06.USD","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661292659","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-08-21","url":"https://stock-news.laohu8.com/highlight/detail?id=2661292659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661292659?lang=en_us&edition=fundamental","pubTime":"2026-08-22 02:45","pubTimestamp":1787337906,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-08-21Nasdaq 100.NDXTop PerformersPercent ChangeTesla IncTSLA.OQ+5.5%Strategy IncMSTR.OQ+5.4%Ross Stores IncROST.OQ+5.0%Alnylam Pharmaceuticals, Inc.ALNY.OQ+3.3%Palantir Technologies Inc.PLTR.OQ+3.0%Bottom PerformersPercent ChangeMarvell Technology, Inc.MRVL.OQ-5.5%American Electric Power Company IncAEP.OQ-3.2%ARM Holdings PLCARM.OQ-2.9%Xcel Energy IncXEL.OQ-2.4%Exelon CorpEXC.OQ-2.2%The Nasdaq 100.NDXgained 73.82 points, or 0.25%, to 29,286.98 and recorded 2 new highs and one new low. 65 stocks rose and 37 fell as advancing issues outnumbered decliners by a about a 1.8-to-1 ratio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I146:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","TESC","MRVL","SG9999000418.SGD","LU1839511570.USD","LU0882574055.USD","LU2089985449.USD","LU0348723411.USD","LU1366192091.USD","LU0964807845.USD","IE00B3T34201.USD","LU0048573561.USD","DTCR","VPU","BILT","LU0985320562.USD","LU1066051811.HKD","LU0672654240.SGD","LU2357305700.SGD","FTXL","IE00B19Z9505.USD","TSLQ","LU2168564495.EUR","LU0823434583.USD","LU1235294995.USD","LU0314106906.USD","GUNZ","IE00B7SZLL34.SGD","LU0708995401.HKD","BK4516","LU2272731865.HKD","BK4511","SHLD","PLTZ","BK4600","LU2471134796.USD","LU0823417653.USD","LU1861215975.USD","07766","LU2449327464.USD","TSLI","LU0642271901.SGD","LU0444971666.USD","PLT","IE00BN8TJ469.HKD","LU1989764748.USD","MSDD","IE00B1XK9C88.USD","LU1778281490.HKD","BK4515","IGV","LU2213496289.HKD","IE00BMPRXR70.SGD","LU2471134952.CNY","IE0004091025.USD","WANT","LU0323591593.USD","TSLT","MSTY.UK","LU1674673428.USD","LU2500361329.USD","LU2290526834.HKD","LU0823411888.USD","LU2326559502.SGD","LU0077335932.USD","3LMI.UK","IE00B19Z3581.USD","LU1823568750.SGD","WNTR","PLOO","MVLL","BK4527","LU2236285917.USD","CRPT","LU0320765992.SGD","PLTL","BK4613","IE00BZ18W456.USD","LU2272731600.USD","TSII","LU0719512351.SGD","MRVU","FDRV","LU2244417387.USD","LU0109394709.USD","LU2458330243.SGD","BK4533","ARM","RSPU","LU2272731782.SGD","TLA","HK0000914660.USD","09799","07366","TSLP","BK4141","LU2362540622.SGD","SPLTRmain","LU2506951958.HKD","LU2417539215.USD","TSYY","ALNY","3SMI.UK","MRVX","BK4592","LU0820562030.AUD","IE00BSNM7G36.USD","LU2403377893.USD","IE00BK4W5M84.HKD","IE00B1BXHZ80.USD","MSII","LU0082616367.USD","BK4606","LU2756315318.SGD","IE00B894F039.SGD","JXI","IE00B19Z8W00.USD","LU1548497426.USD","LU1720051108.HKD","IE00BMPRXN33.USD","ARMW","LU0170899867.USD","MSOO","TSLG","PLTY","BK4094","CRSH","MSTU","LU2362541513.USD","LU0133085943.USD","LU0889565916.HKD","LU2322448957.HKD","ELOL","LU2087621335.USD","FXL","LU2543165471.USD","LU1861558580.USD","TSLW","SPRX","LU2506952097.USD","IE00BLSP4239.USD","WUGI","BK4596","IE00BK4W5L77.USD","LU0950375773.USD","LU0056508442.USD","TRUU","LU2250418816.HKD","BK4548","MSTR","LU0957808578.USD","LU1303367103.USD","IE00BMPRXQ63.HKD","IMST","SG9999015986.USD","FUTY","AIPI","IE0002270589.USD","LU2360107168.USD","LU2506951875.HKD","AEP","LU0345770308.USD","UTES","IE00BZ9MQY76.HKD","LU0210536198.USD","LU1119994496.HKD","LU0053666078.USD","QQQA","IE00BWXC8680.SGD","LU0198837287.USD","LU2249611893.SGD","IE00B19Z8X17.USD","ARMG","09366","MSTC","LU1815336760.USD","LU1551013425.SGD","LU1093756325.SGD","BK4534","LU0943347566.SGD","TESL","TSL","PLTR","LU2063271972.USD","LU0187121727.USD","BITQ","IE0034235303.USD","LU1914381329.SGD","LU0476273544.USD","LU0081259029.USD","LU2931357623.SGD","LU1852331112.SGD","LU1066051498.USD","FDTX","07799","IE00B19Z3B42.SGD","LU1267930730.SGD","LU2346227817.USD","LU1992135399.USD","OWNB","LU1642822529.SGD","TSLL","LU0316494557.USD","IE00BJLML261.HKD","LU2322448791.USD","BK4612","MTYY","LU1861220033.SGD","SMST","BK4551","LU1316542783.SGD","09766","LU1506573853.SGD","LU2637428348.USD","UPW","LU0823414478.USD","LU1989764664.SGD","APED","LU1169590202.USD","TRFK","LU0320765059.SGD","IDRV","PLTD","LU1066051225.USD","LU0742534661.SGD","BK4099","EYES","TSLY","LU2756315664.SGD","MSTK","LU1084165304.USD","LU0234572021.USD","LU0234570918.USD","MSTP","LU0154236417.USD","ARMA","LU1435385759.SGD","IE00BBT3K403.USD","BK4081","LU1066053197.SGD","MSST","LU0786609619.USD","FAI","TSDD","MSTY","EXC","LU1718418525.SGD","LU2360106780.USD","PLTG","LU1169589451.USD","PLTI","BK4605","LU2420271590.USD","STSLAmain","ARTY","BK4550","LU0127658192.USD","TEST","ZAP","XNTK","XEL","LMI3.UK","LU0097036916.USD","BK4023","LU0114720955.EUR","LU1674673691.USD","LU0345770993.USD","LU0061475181.USD","BK4543","HK0000914686.HKD","LU2750360997.AUD","LU0820561909.HKD","LU2458330169.SGD","BK4139","IE00BMQBXF63.USD","LU1992135472.HKD","PLTU","LU0345769128.USD","LU2098885051.SGD","LIT","PLTA","LU0274383776.USD","LU2168563687.JPY","BK4581","LU0109391861.USD","LU2362541273.HKD","AIS","LU2168564222.USD","SG9999015978.USD","LU2602419157.SGD","FXU","09399","LU2471134523.USD","AIFD","LU0345769631.USD","TSLZ","LU0823421416.USD","BK4555","LU2896262040.SGD","WATS","PLTW","SG9999015945.SGD","LU1551013342.USD","SMHX","PLYY","BK4598","LU2463526074.USD","BK4609","LU2108987350.USD","IE0004086264.USD","LU0689472784.USD","LU2750360641.GBP","TSLR","LU2473716301.USD","LU0823417737.USD","SG9999015952.SGD","LU2471134879.HKD","TSLA","BK4585","LU0823434740.USD","LU1145028129.USD","MSTZ","LU1429558221.USD","XLU","BK4588","LU2462157665.USD","LU1629891620.HKD","LU0251131958.USD","ROST","TSLO","PBE","BK4604","IE00B19Z9P08.USD","IE00BLSP4452.SGD","SMOG","LU0823421333.USD","LU0444973449.USD","URAN","GNMX","LU2168564065.EUR","SMI3.UK","LU1861559042.SGD","LU1261432733.SGD","MSTX","07399","RNWZ","LU1720051017.SGD","ARMU","LU1894683264.USD","LU0466842654.USD","MST","LU0251142724.SGD","BK4595","LU0266013472.USD","GTEK","BK4547","LU2023250330.USD","IE00B19Z9Z06.USD","BK4574","LU2168564149.EUR","LU1093756168.USD","LU1046421795.USD","IE00B29SXL02.USD","LU1232071149.USD","MSTW","IE00BZ18W340.USD","PTIR","TSLS","LU2506952170.USD","SOXY","IE00B29SXK94.USD","LU2456880835.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","BK4585","TBXU","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","LU1061106388.HKD","BK4588","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK4533","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}